GT Medical Technologies raises $50.1M in Rule 506(b) private equity offering
GT Medical Technologies, a Delaware health care company, has sold $50,056,676 of a $100,056,698 equity offering under Regulation D Rule 506(b), attracting 39 investors since May 8, 2026. The offering remains half-subscribed with $50,000,022 available, and no sales compensation was paid.
$50.1M
$100Mequity
Key facts
- $50,056,676 sold to date of $100,056,698 target
- 39 investors to date
- First sale: May 8, 2026
- Rule 506(b) exemption claimed
- Equity, options, and securities to be acquired offered
- $50,000,022 remaining in offering
Why it matters
GT Medical Technologies has achieved 50% subscription of its target raise, signaling moderate investor demand for its equity at this stage of capitalization.
Share
Derived from D filed 2026-07-22. Not investment advice. Figures are extracted from the filing; prose is AI-assisted. View the source filing on SEC.gov →